Stockholders' Equity (Tables)

12 Months Ended

Jun. 30, 2016

Stockholders' Equity [Abstract]

Schedule Of Option Activity

			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		2,809,238	$	29.63	2.5
Granted		336,176		58.22
Exercised*		(1,189,787)		22.68
Forfeited		(31,398)		41.52
Outstanding at end of period		1,924,229	$	38.70	3.2
Exercise price of granted options	$	58.22
Options exercisable at end of period		1,367,907	$	32.31

*  Includes 13,747 shares netted for tax.

Schedule Of Activity Of Restricted Stock Units

		Weighted Average Grant-Date Fair Value		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period	2,312,529	$	43.65	1.2
Granted	725,145		54.83
Vested*	(835,255)		39.45
Expired	(251,945)		38.22
Forfeited	(88,964)		45.79
Outstanding at end of period	1,861,510	$	50.52	1.4

*  Includes 216,408 shares netted for tax.

Schedule Of Total Stock-Based Compensation Costs Incurred And Associated Tax Benefit Recognized

	2016		2015		2014
Cost of sales - capitalized as part of inventory	$	2,731	$	2,605	$	2,621
Selling, general and administrative expenses		36,994		38,755		34,667
Research and development expenses		6,683		6,495		6,169
Stock-based compensation costs		46,408		47,855		43,457
Tax benefit*		(25,020)		(14,100)		(11,744)
Stock-based compensation costs, net of tax benefit	$	21,388	$	33,755	$	31,713

*Includes an additional tax benefit of $11.2 million for the year ended June 30, 2016,  associated with the early adoption of ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting”,discussed in  Note 3 - New Accounting Pronouncements.